Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Asset Turnover	-	1.93	2.22	1.43	-
Quick Ratio	-	0.57	1.67	1.83	0.45
Current Ratio	0.04	0.60	1.68	2.98	1.97
Return on Equity (ROE)	-	67.94%	111.27%	63.96%	-
Return on Assets (ROA)	-	30.09%	53.98%	28.75%	-
Return on Capital (ROIC)	-	53.62%	87.78%	51.24%	-
Return on Capital Employed (ROCE)	180.70%	92.10%	103.20%	90.90%	96.40%
Payout Ratio	99.26%	120.13%	35.22%	130.67%	289.15%
Buyback Yield / Dilution	-	-27400.00%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.